Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Fri 20 Nov 2009, 14:41 CMP - Cipla Medpro - Dealing In Securities By Directors
CMP
CMP                                                                             
CMP - Cipla Medpro - Dealing In Securities By Directors                         
CIPLA MEDPRO SOUTH AFRICA LIMITED                                               
(formerly Enaleni Pharmaceuticals Limited)                                      
(Incorporated in the Republic of South Africa)                                  
(Registration number 2002/018027/06)                                            
(ISIN Number: ZAE000128179   Share Code: CMP)                                   
("Cipla Medpro" or "the Company")                                               
DEALING IN SECURITIES BY DIRECTORS                                              
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the 
following information relates to the dealing in securities by directors of Cipla
Medpro:                                                                         
Executive director:                     J S Smith                               
Company:                                Cipla Medpro                            
Number of shares:                       2 345 711                               
Strike price:                           R4.78 per share                         
Value of transaction:                   R11 212 498                             
Extent of interest:                     Direct beneficial                       
Date of transaction:                    18 November 2009                        
Nature of transaction:                  Grant and acceptance of share           
options in terms of the Cipla Medpro     
                                       South Africa Share Option Trust          
Written clearance to deal obtained:     Yes                                     
Executive director:                     C Aucamp                                
Company:                                Cipla Medpro                            
Number of shares:                       774 728                                 
Strike price:                           R4.78 per share                         
Value of transaction:                   R3 703 199                              
Extent of interest:                     Direct beneficial                       
Date of transaction:                    18 November 2009                        
Nature of transaction:                  Grant and acceptance of share           
                                       options in terms of the Cipla Medpro     
South Africa Share Option Trust          
Written clearance to deal obtained:     Yes                                     
Durban                                                                          
20 November 2009                                                                
Sponsor                                                                         
Nedbank Capital                                                                 
Date: 20/11/2009 14:41:29 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: